Daebonglsco

대봉엘에스 · 078140

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$69.1M (₩95.3B)

Overview

Daebonglsco makes products people ingest or apply to their skin, spanning health and beauty formulations, designed to be safe and effective for a broad consumer base.

Its products serve end-users in the medical beauty and biotech spaces, sitting at the intersection of personal care and health care. The company operates across multiple business divisions built on platform-development technology accumulated since its founding, and is listed on KOSDAQ, South Korea's tech and small-cap stock exchange.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$74M

▲ +8.6% YoY

Operating profit · FY2025

US$5.3M

▼ −19.0% YoY

Net income · FY2025

US$8.7M

▲ +23.3% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$63.5M(₩87.6B)	US$68.1M(₩94B)	US$74M(₩102.1B)
Operating profit	US$2.8M(₩3.8B)	US$6.6M(₩9.1B)	US$5.3M(₩7.3B)
Net income	US$4.5M(₩6.2B)	US$7M(₩9.7B)	US$8.7M(₩11.9B)

Revenue

FY2023US$63.5M
FY2024US$68.1M
FY2025US$74M

Operating profit

FY2023US$2.8M
FY2024US$6.6M
FY2025US$5.3M

Net income

FY2023US$4.5M
FY2024US$7M
FY2025US$8.7M

Key ratios (FY2025)

ROE

6.8%

Debt/Eq

51.5%

Op. margin

7.2%

Net margin

11.7%

Rev. YoY

▲ +8.6%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?